MEP15608A - NOVEL SOLID BODY FORMS OF MESOPROGESTIN 11beta-[4E-(HYDROXYIMINOMETHYL)-PHENYL]-17alpha-METHOXYMETHYL-17beta-METHOXY-ESTRA-4,9-DIEN-3-ONE - Google Patents

NOVEL SOLID BODY FORMS OF MESOPROGESTIN 11beta-[4E-(HYDROXYIMINOMETHYL)-PHENYL]-17alpha-METHOXYMETHYL-17beta-METHOXY-ESTRA-4,9-DIEN-3-ONE

Info

Publication number: MEP15608A
Authority: ME; Montenegro
Prior art keywords: mesoprogestin; hydroxyiminomethyl; estra; dien; methoxymethyl
Prior art date: 2000-05-23

Application number

MEP-156/08A

Other languages

Bosnian (bs)

English (en)

Croatian (hr)

Inventor

Detlef Grawe

Peter Hoesel

Uwe Mueller

Gabriele Winter

Original Assignee

Bayer Schering Pharma Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-05-23

Filing date

2001-05-09

Publication date

2010-06-10

2001-05-09 Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag

2010-06-10 Publication of MEP15608A publication Critical patent/MEP15608A/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/36—Antigestagens
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
- C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Gynecology & Obstetrics (AREA)
Diabetes (AREA)
Pregnancy & Childbirth (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

MEP-156/08A 2000-05-23 2001-05-09 NOVEL SOLID BODY FORMS OF MESOPROGESTIN 11beta-[4E-(HYDROXYIMINOMETHYL)-PHENYL]-17alpha-METHOXYMETHYL-17beta-METHOXY-ESTRA-4,9-DIEN-3-ONE MEP15608A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP00110887A EP1157996A1 (de)	2000-05-23	2000-05-23	Neue Festkörperformen des Mesoprogestins 11Beta-[4E-(Hydroxyiminomethyl)-phenyl]-17Alpha-methoxymethyl-17Beta-methoxy-estra-4,9-dien-3-on
PCT/EP2001/005237 WO2001090137A2 (de)	2000-05-23	2001-05-09	NEUE FESTKÖRPERFORMEN DES MESOPROGESTINS 11β-[4E-(HYDROXYIMINOMETHYL)-PHENYL]-17α-METHOXYMETHYL-17β-METHOXY-ESTRA-4,9-DIEN-3-ON

Publications (1)

Publication Number	Publication Date
MEP15608A true MEP15608A (en)	2010-06-10

Family

ID=8168805

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MEP-156/08A MEP15608A (en)	2000-05-23	2001-05-09	NOVEL SOLID BODY FORMS OF MESOPROGESTIN 11beta-[4E-(HYDROXYIMINOMETHYL)-PHENYL]-17alpha-METHOXYMETHYL-17beta-METHOXY-ESTRA-4,9-DIEN-3-ONE

Country Status (30)

Country	Link
US (1)	US7799770B2 (xx)
EP (3)	EP1157996A1 (xx)
JP (1)	JP2003534350A (xx)
KR (1)	KR100553292B1 (xx)
CN (1)	CN100384867C (xx)
AT (1)	ATE397617T1 (xx)
AU (2)	AU5634401A (xx)
BG (1)	BG65968B1 (xx)
BR (1)	BR0111058A (xx)
CA (1)	CA2409869C (xx)
CZ (1)	CZ2003620A3 (xx)
DE (1)	DE50114012D1 (xx)
DK (1)	DK1292607T3 (xx)
EA (1)	EA005623B1 (xx)
EC (2)	ECSP024358A (xx)
ES (1)	ES2307613T3 (xx)
HR (2)	HRP20021032B1 (xx)
HU (1)	HUP0301956A3 (xx)
IL (2)	IL152868A0 (xx)
ME (1)	MEP15608A (xx)
MX (1)	MXPA02011524A (xx)
NO (1)	NO327004B1 (xx)
NZ (1)	NZ522768A (xx)
PL (1)	PL358789A1 (xx)
PT (1)	PT1292607E (xx)
RS (1)	RS50493B (xx)
SK (1)	SK2922003A3 (xx)
UA (1)	UA73988C2 (xx)
WO (1)	WO2001090137A2 (xx)
ZA (1)	ZA200209322B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10218107A1 (de) *	2002-04-23	2003-11-20	Jenapharm Gmbh	Verfahren zum Herstellen von Kristallen von Steroiden, danach erhältliche Kristalle und deren Verwendung in pharmazeutischen Formulierungen
DE10218109A1 (de) *	2002-04-23	2003-11-20	Jenapharm Gmbh	Verfahren zum Herstellen von Kristallen, danach erhältliche Kristalle und deren Verwendung in pharmazeutischen Formulierungen
TW200640450A (en) *	2005-01-18	2006-12-01	Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag	Amorphous and crystalline forms of dorzolamide hydrochloride and processes of making same
US20090054387A1 (en)	2006-04-18	2009-02-26	Detlef Grawe	Method for preparing 4-[17beta-methoxy-17alpha-methoxymethyl-3-oxestra-4,9-dien-11beta-yl]benzaldehyde (E)-oxime (asoprisnil)
DE102006018888A1 (de) *	2006-04-18	2007-10-25	Bayer Schering Pharma Ag	Verfahren zur Herstellung von 4-[17beta-Methoxy-17alpha-methoxymethyl-3-oxoestra-4,9-dien-11beta-yl]benzaldehyd-(E)-oxims (Asoprisnil)
EP1862468A1 (de) *	2006-06-02	2007-12-05	Bayer Schering Pharma Aktiengesellschaft	Kristallines 11beta-(4-Acetylphenyl)-20,20,21,21,21-pentafluor-17-hydroxy-19-nor-17alpha-pregna-4,9-dien-3-on
DE102009034367A1 (de)	2009-07-20	2011-01-27	Bayer Schering Pharma Aktiengesellschaft	17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzyliden-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102009034362A1 (de)	2009-07-20	2011-01-27	Bayer Schering Pharma Aktiengesellschaft	17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034366A1 (de)	2009-07-20	2011-01-27	Bayer Schering Pharma Aktiengesellschaft	17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylenoxyalkylenaryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034368A1 (de)	2009-07-20	2011-01-27	Bayer Schering Pharma Aktiengesellschaft	17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylenphenyl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034526A1 (de)	2009-07-21	2011-02-10	Bayer Schering Pharma Aktiengesellschaft	17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-ethinylphenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102009034525A1 (de)	2009-07-21	2011-01-27	Bayer Schering Pharma Aktiengesellschaft	17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102010007722A1 (de)	2010-02-10	2011-08-11	Bayer Schering Pharma Aktiengesellschaft, 13353	Progesteronrezeptorantagonisten
DE102010007719A1 (de)	2010-02-10	2011-08-11	Bayer Schering Pharma Aktiengesellschaft, 13353	Progesteronrezeptorantagonisten

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4332283A1 (de) *	1993-09-20	1995-04-13	Jenapharm Gmbh	Neue 11-Benzaldoximestradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19610667C2 (de) *	1996-03-08	1998-04-09	Schering Ag	(Z)-11ß-[4-(Dimethylamino)phenyl]17ß-hydroxy-17alpha-(3-hydroxy-1-propenyl)estr-4-en-3-on als kristallines Ansolvat
WO2001009116A2 (en) *	1999-07-29	2001-02-08	Eli Lilly And Company	A NOVEL CRYSTALLINE FORM OF 6-HYDROXY-3- (4-[2-(PIPERIDIN-1-YL) ETHOXY]PHENOXY)- 2-(4-METHOXYPHENYL)BENZO[b]THIOPHENE HYDROCHLORIDE

2000
- 2000-05-23 EP EP00110887A patent/EP1157996A1/de not_active Withdrawn
2001
- 2001-05-09 IL IL15286801A patent/IL152868A0/xx unknown
- 2001-05-09 MX MXPA02011524A patent/MXPA02011524A/es active IP Right Grant
- 2001-05-09 BR BR0111058-6A patent/BR0111058A/pt not_active IP Right Cessation
- 2001-05-09 ME MEP-156/08A patent/MEP15608A/xx unknown
- 2001-05-09 US US10/296,463 patent/US7799770B2/en active Active
- 2001-05-09 DK DK01929632T patent/DK1292607T3/da active
- 2001-05-09 RS YUP-887/02A patent/RS50493B/sr unknown
- 2001-05-09 HR HR20021032A patent/HRP20021032B1/xx not_active IP Right Cessation
- 2001-05-09 CA CA002409869A patent/CA2409869C/en not_active Expired - Lifetime
- 2001-05-09 SK SK292-2003A patent/SK2922003A3/sk not_active Application Discontinuation
- 2001-05-09 EA EA200201192A patent/EA005623B1/ru not_active IP Right Cessation
- 2001-05-09 AU AU5634401A patent/AU5634401A/xx active Pending
- 2001-05-09 EP EP01929632A patent/EP1292607B1/de not_active Expired - Lifetime
- 2001-05-09 JP JP2001586324A patent/JP2003534350A/ja active Pending
- 2001-05-09 HU HU0301956A patent/HUP0301956A3/hu unknown
- 2001-05-09 AU AU2001256344A patent/AU2001256344B2/en not_active Ceased
- 2001-05-09 EP EP07115136A patent/EP1862469A2/de not_active Withdrawn
- 2001-05-09 CN CNB018099394A patent/CN100384867C/zh not_active Expired - Fee Related
- 2001-05-09 KR KR1020027015762A patent/KR100553292B1/ko not_active Expired - Fee Related
- 2001-05-09 DE DE50114012T patent/DE50114012D1/de not_active Expired - Lifetime
- 2001-05-09 WO PCT/EP2001/005237 patent/WO2001090137A2/de not_active Ceased
- 2001-05-09 NZ NZ522768A patent/NZ522768A/en unknown
- 2001-05-09 ES ES01929632T patent/ES2307613T3/es not_active Expired - Lifetime
- 2001-05-09 CZ CZ2003620A patent/CZ2003620A3/cs unknown
- 2001-05-09 AT AT01929632T patent/ATE397617T1/de not_active IP Right Cessation
- 2001-05-09 PT PT01929632T patent/PT1292607E/pt unknown
- 2001-05-09 HR HR20080423A patent/HRP20080423A2/xx not_active Application Discontinuation
- 2001-05-09 PL PL01358789A patent/PL358789A1/xx not_active IP Right Cessation
- 2001-09-05 UA UA20021210147A patent/UA73988C2/uk unknown
2002
- 2002-11-14 IL IL152868A patent/IL152868A/en not_active IP Right Cessation
- 2002-11-15 ZA ZA200209322A patent/ZA200209322B/en unknown
- 2002-11-22 EC EC2002004358A patent/ECSP024358A/es unknown
- 2002-11-22 NO NO20025613A patent/NO327004B1/no not_active IP Right Cessation
2003
- 2003-02-14 BG BG107557A patent/BG65968B1/bg unknown
2008
- 2008-10-22 EC EC2008004358A patent/ECSP084358A/es unknown

Also Published As

Publication number	Publication date
HUP0301956A3 (en)	2010-03-29
EP1292607B1 (de)	2008-06-04
ECSP084358A (es)	2008-11-27
WO2001090137A3 (de)	2002-04-04
IL152868A (en)	2009-08-03
AU2001256344B2 (en)	2007-01-25
BG107557A (bg)	2004-01-30
EA005623B1 (ru)	2005-04-28
US20040006241A1 (en)	2004-01-08
NO327004B1 (no)	2009-04-06
ES2307613T3 (es)	2008-12-01
HRP20021032A2 (en)	2005-02-28
RS50493B (sr)	2010-03-02
EA200201192A1 (ru)	2003-06-26
KR20030028742A (ko)	2003-04-10
WO2001090137A2 (de)	2001-11-29
IL152868A0 (en)	2003-06-24
SK2922003A3 (en)	2003-08-05
CA2409869A1 (en)	2002-11-20
YU88702A (sh)	2006-01-16
EP1157996A1 (de)	2001-11-28
DK1292607T3 (da)	2008-10-13
NO20025613D0 (no)	2002-11-22
CN100384867C (zh)	2008-04-30
ZA200209322B (en)	2005-03-10
HRP20021032B1 (hr)	2008-09-30
DE50114012D1 (en)	2008-07-17
CA2409869C (en)	2009-02-03
AU2001256344B8 (en)	2001-12-03
HRP20080423A2 (en)	2008-10-31
NO20025613L (no)	2002-11-22
ECSP024358A (es)	2003-03-31
HUP0301956A2 (hu)	2003-09-29
BR0111058A (pt)	2003-04-15
PT1292607E (pt)	2008-09-15
KR100553292B1 (ko)	2006-02-22
JP2003534350A (ja)	2003-11-18
EP1292607A2 (de)	2003-03-19
MXPA02011524A (es)	2004-09-10
EP1862469A2 (de)	2007-12-05
UA73988C2 (en)	2005-10-17
NZ522768A (en)	2005-03-24
PL358789A1 (en)	2004-08-23
CN1430624A (zh)	2003-07-16
ATE397617T1 (de)	2008-06-15
CZ2003620A3 (cs)	2003-08-13
BG65968B1 (bg)	2010-07-30
US7799770B2 (en)	2010-09-21
AU5634401A (en)	2001-12-03

Publication	Publication Date	Title
MEP15608A (en)	2010-06-10	NOVEL SOLID BODY FORMS OF MESOPROGESTIN 11beta-[4E-(HYDROXYIMINOMETHYL)-PHENYL]-17alpha-METHOXYMETHYL-17beta-METHOXY-ESTRA-4,9-DIEN-3-ONE
HUT76476A (en)	1997-09-29	Morpholine and thiomorpholine derivatives, process for the preparation thereof and pharmaceutical compositions containing them
MXPA02012033A (es)	2003-04-25	Derivados de 2-aminocarbonil-9h-purina.
PT1263724E (pt)	2005-09-30	Novos compostos
PL361361A1 (en)	2004-10-04	Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
AR027261A1 (es)	2003-03-19	Linezolid forma cristalina ii
DE602004011966D1 (en)	2008-04-03	Heterocyclylverbindungen
PL361282A1 (en)	2004-10-04	Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
IL160171A0 (en)	2004-07-25	Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
TW200635942A (en)	2006-10-16	18-methyl-19-nor-17-pregn-4-ene-21,17-carbolactones, as well as pharmaceurical preparations that contain the latter
TW200610758A (en)	2006-04-01	Alpha crystalline form of strontium ranelate, a process for its preparation, and pharmaceutical compositions containing it
HUP0301231A2 (hu)	2003-08-28	Proteáz inhibitorok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
IS6919A (is)	2003-08-20	Stöðug lyfjablanda sem felur í sér torsemíð afbrigði II
BG107407A (en)	2004-01-30	Novel polymorph v of torasemide
CY1112542T1 (el)	2015-12-09	Χρηση ενος οιστρογονου για τη βιομηχανικη κατασκευη μιας συνθεσης που περιεχει οιστρογονο για τη θεραπεια ατροφικης κολπιτιδας
FI932873A0 (fi)	1993-06-21	D-homo-(16-en)-11b-aryl-4-estrener, foerfarande foer deras framstaellningoch deras anvaendning som laekemedel
EE200300124A (et)	2005-04-15	17alfa-fluoroalküülsteroidid, nende valmistamismeetod ja neid ühendeid sisaldavad farmatseutilised kompositsioonid
DE60103034D1 (de)	2004-06-03	Neue phenylheteroalkylamin-derivate
BR0112957A (pt)	2003-07-08	Composto, método de tratamento, uso de um composto, e, composição farmacêutica
ATE343585T1 (de)	2006-11-15	Steroide, ihre herstellung , pharmazeutische zusammensetzungen mit ihnen und verwendungen dieser verbindungen
AU2002214467A1 (en)	2002-05-21	Novel compounds
IE780606L (en)	1978-09-28	A-nor-androstane and estrane steroids
MY128457A (en)	2007-02-28	2-aminocarbonyl-9h-purine derivatives
NO20025201L (no)	2002-10-30	19-nor-17<alfa>-pregna-1,3,5(10)-trien-17<beta>-oler med en 21,16<alfa>-laktonring
YU46731B (sh)	1994-04-05	Postupak za proizvodnju zeolita